The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems-Reference-Cited by-同舟云学术

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems

Published:2017-06-09 Issue:3 Volume:102 Page:502-510
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Luzum JA¹²,Pakyz RE³,Elsey AR⁴,Haidar CE⁵,Peterson JF⁶⁷,Whirl-Carrillo M⁸,Handelman SK²,Palmer K³,Pulley JM⁹,Beller M¹⁰,Schildcrout JS¹¹,Field JR⁹,Weitzel KW⁴,Cooper-DeHoff RM⁴,Cavallari LH⁴,O'Donnell PH¹²,Altman RB⁸,Pereira N¹³,Ratain MJ¹²,Roden DM⁶,Embi PJ¹⁴,Sadee W²¹⁵,Klein TE⁸,Johnson JA⁴,Relling MV⁵,Wang L¹⁶,Weinshilboum RM¹⁶,Shuldiner AR³,Freimuth RR¹⁷,

Affiliation:

1. Department of Clinical Pharmacy, College of Pharmacy; University of Michigan; Ann Arbor Michigan USA

2. Center for Pharmacogenomics, College of Medicine; Ohio State University; Columbus Ohio USA

3. Program for Personalized and Genomic Medicine, School of Medicine; University of Maryland; Baltimore Maryland USA

4. Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics; University of Florida; Gainesville Florida USA

5. Department of Pharmaceutical Sciences; St. Jude Children's Research Hospital; Memphis Tennessee USA

6. Department of Medicine; Vanderbilt University School of Medicine; Nashville Tennessee USA

7. Department of Biomedical Informatics; Vanderbilt University School of Medicine; Nashville Tennessee USA

8. Stanford University School of Medicine; Palo Alto California USA

9. Vanderbilt Institute for Clinical and Translational Research; Vanderbilt University School of Medicine; Nashville Tennessee USA

10. Office of Research Informatics; Vanderbilt University School of Medicine; Nashville Tennessee USA

11. Department of Statistics; Vanderbilt University School of Medicine; Nashville Tennessee USA

12. Center for Personalized Therapeutics; University of Chicago; Chicago Illinois USA

13. Division of Cardiovascular Diseases; Mayo Clinic; Rochester Minnesota USA

14. Department of Biomedical Informatics; Ohio State University; Columbus Ohio USA

15. Department of Cancer Biology and Genetics, College of Medicine; Ohio State University; Columbus Ohio USA

16. Department of Molecular Pharmacology & Experimental Therapeutics; Mayo Clinic; Rochester Minnesota USA

17. Department of Health Sciences Research; Mayo Clinic; Rochester Minnesota USA

Funder

National Institutes of Health

National Cancer Institute

American Lebanese Syrian Associated Charities

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. United States Food and Drug Administration Table of pharmacogenomic biomarkers in drug labeling http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm

2. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network;Relling;Clin. Pharmacol. Ther.,2011

3. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey;Stanek;Clin. Pharmacol. Ther.,2012

4. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation;Shuldiner;Clin. Pharmacol. Ther.,2013

5. Implementing genomic medicine in the clinic: the future is here;Manolio;Genet. Med.,2013

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotype-Guided Antiplatelet Therapy;Journal of the American College of Cardiology;2024-09

2. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

3. Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting;European Journal of Human Genetics;2024-02-29

4. Trends and implementation of preemptive pharmacogenomic testing;Comprehensive Precision Medicine;2024

5. SLCO1B1functional variants and statin-induced myopathy in people with recent genealogical ancestors from Africa: a population-based real-world study;2023-12-03